Pharmacoeconomic Considerations in the Treatment of Multiple Sclerosis

Author： Sharac Jessica   McCrone Paul   Sabes-Figuera Ramon  

Publisher： Adis International

ISSN： 0012-6667

Source： Drugs, Vol.70, Iss.13, 2010-09, pp. : 1677-1691

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacoeconomic considerations of multiple sclerosis therapy with the new disease-modifying agents

By Amato Maria Pia  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2115-2126

Informa Healthcare

Access to resources Recommend Favorite

Therapeutic Options in the Treatment of Multiple Myeloma: Pharmacoeconomic and Quality-of-Life Considerations

By Wisløff F.  

PharmacoEconomics, Vol. 16, Iss. 4, 1999-10 ,pp. : 329-341

Adis International

Access to resources Recommend Favorite

Pharmacoeconomic evidence and considerations for triptan treatment of migraine

By Getsios Denis   Caro J Jaime  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 3, 2002-03 ,pp. : 237-248

Informa Healthcare

Access to resources Recommend Favorite

Considerations in the treatment of anxiety disorders: a pharmacoeconomic review

By Grudzinski Amy Nicole  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 10, 2001-10 ,pp. : 1557-1569

Informa Healthcare

Access to resources Recommend Favorite

Multiple sclerosis and its treatment

By Giovannoni Gavin   Miller David H  

Clinical Medicine, Vol. 33, Iss. 4, 1999-07 ,pp. : 315-322

Royal College Of Physicians

Access to resources Recommend Favorite